Substance P (SP) Mediates Production of Stem Cell Factor and Interleukin-1 in Bone Marrow Stroma: Potential Autoregulatory Role for These Cytokines in SP Receptor Expression and Induction
Overview
Authors
Affiliations
Substance P (SP) is a neuropeptide widely distributed in the nervous system. Its release within the bone marrow (BM) can mediate bidirectional neurohematopoietic communication via specific receptors: neurokinin-1R (NK-1R), NK-2R, or NK-3R. We have previously reported that SP effects on hematopoiesis are mediated by an NK-1-type receptor, the BM stroma, and growth factors. Here, we have studied the induction of stem cell factor (SCF) and interleukin-1 (IL-1) by SP in stroma. At 10(-9) mol/L SP, cytokine levels in supernatants were IL-1 alpha, 20 +/- 5 ng/mL; IL-1 beta, 40 +/- 10 ng/mL; and SCF, nondetectable; and the cell-associated levels were SCF, 21 +/- 2 ng/mL; IL-1 alpha, 90 +/- 6 ng/mL; and IL-1 beta, 45 +/- 3 ng/mL. Reverse transcriptase-polymerase chain reaction and ligand-binding studies with stroma stimulated by these two cytokines resulted in (1) NK-1-like receptor mRNA accumulation and (2) downregulation of SP binding sites (day 1) followed by an upregulation (day 3). Low numbers of high-affinity receptors were expressed by day 1 but not by day 3. The results indicate that SP induces IL-1 and SCF in stroma and that these cytokines have the potential to autoregulate NK-R.
Nguyen L, Cho M, Nguyen T, Park H, Nguyen H, Mykhailova K Cell Biosci. 2023; 13(1):212.
PMID: 37968728 PMC: 10652611. DOI: 10.1186/s13578-023-01165-6.
Pocket ACEs: Discovering new function within an old player.
Leong M, Li X, Chaum M Front Physiol. 2023; 14:1151908.
PMID: 36969603 PMC: 10036365. DOI: 10.3389/fphys.2023.1151908.
Singh R, Naderi A, Cho W, Ortiz G, Musayeva A, Dohlman T Ocul Surf. 2022; 25:142-153.
PMID: 35779793 PMC: 10285737. DOI: 10.1016/j.jtos.2022.06.007.
Neural regulation of bone marrow adipose tissue.
Zhang X, Hassan M, Scheller E Best Pract Res Clin Endocrinol Metab. 2021; 35(4):101522.
PMID: 33766429 PMC: 8440660. DOI: 10.1016/j.beem.2021.101522.
Substance P enhances the therapeutic effect of MSCs by modulating their angiogenic potential.
Hong H, Kim S, Jin Y, Son Y J Cell Mol Med. 2020; 24(21):12560-12571.
PMID: 32985796 PMC: 7687016. DOI: 10.1111/jcmm.15804.